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Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is a method 
of neuromodulation used for refractory focal epilepsy. We report a patient suffering from 
drug-resistant epilepsy who developed novel visual symptoms and atypical seizures 
with the onset of ANT-DBS therapy. Rechallenge under video electroencephalography 
recording confirmed that lowering the stimulation voltage alleviated these symptoms. 
Subsequent stimulation with the initial voltage value did not cause the recurrence of 
either the visual symptoms or the new seizure type, and appeared to alleviate the 
patient’s seizures in long-term follow-up. We therefore hypothesize that the occurrence 
of stimulation induced seizures at the onset of DBS therapy should not be considered 
as a failure in the DBS therapy, and the possibility of a subsequent favorable response 
to the treatment still exists.
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BaCKGRoUND
Epilepsy is a significant neurologic disorder which can greatly affect a patient’s quality of life. Epilepsy 
has a prevalence of up to 1.0% (1), and approximately one-third of patients with epilepsy do not 
gain sufficient benefit from treatment with antiepileptic drugs (AEDs) (2). Even though some of 
these cases can be treated with resective surgery or vagal nerve stimulation (VNS), adequate seizure 
control is still not achieved in all patients. This group of patients must be considered as possible 
candidates for deep brain stimulation (DBS) therapy. DBS is a method of neuromodulation with the 
aim to modulate the activity of epileptic brain networks in a way that suppresses epileptic seizures. 
Although its exact mechanisms remain to be completely understood, DBS has achieved positive 
treatment results in both animal and human studies (2–16).
The Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE) trial was a 
multicenter double-blinded randomized controlled trial, in which a group of 110 patients received 
DBS of the anterior nucleus of the thalamus (ANT) (5). In the blinded phase, patients were divided 
into control and stimulation groups, and only the stimulation group received DBS. After the blinded 
phase, both groups received stimulation. The SANTE study group reported of two patients who 
FIGURe 1 | The locations of the deep brain stimulation leads in coronal (a) and sagittal (B) slices. Panels (C–e) illustrate the estimated distribution of the 
electrical field (orange) generated by different active contacts (red) in both right and left ANT (green). Inactive contacts are represented with blue color. Images 
were generated using the SureTune software (Medtronic, Minneapolis, MN, USA). From bottom to top, contacts are labeled as 0, 1, 2, and 3 on the left side and 
as 8, 9, 10, and 11 on the right side. (C) Contacts 1 and 9 are active. The electrical field completely misses the ANT. (D) Contacts 2 and 10 are active. The 
electrical field still barely reaches the ANT. (e) Contacts 3 and 11 are active. The electrical field extends to the inferior section of ANT. Clinical effect was achieved 
only with this setting.
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experienced “acute, transient stimulation-associated seizures.” 
One of these patients is more widely known as the “outlier patient.” 
This patient experienced a remarkable amount of atypical sei-
zures due to ANT stimulation and the onset of these seizures was 
evidently related to the stimulation. This patient was labeled as an 
outlier and eliminated from the statistical analysis. What makes 
the outlier patient intriguing is the fact that the same stimulation 
parameters initially causing these atypical seizures later led to a 
decrease in the patient’s seizure frequency.
We report a case of a patient resembling the outlier of the 
SANTE trial. During video electroencephalography (vEEG) 
recording, our patient responded to ANT-DBS therapy with 
similar occurrence of a new type of seizure as well as distinct 
visual symptoms. Equally in the current case, the initial unfavora-
ble response evolved into a beneficial treatment outcome for the 
patient.
Case pReseNtatIoN
We present a case of a 30-year-old (at the time of vEEG-monitoring 
in 2011) male patient. The patient has given written consent for 
the publication of this case report. Our patient was diagnosed 
with temporal lobe epilepsy with brief complex partial seizures 
[focal unaware, as defined by ILAE 2017 classification of seizure 
types (17)] at the age of 11, with some seizures propagating to 
secondarily generalized tonic–clonic seizures [focal to bilateral 
tonic–clonic, ILAE 2017 (17)]. A specific characteristic for the 
seizures of this patient was the usual occurrence of tonic–clonic 
seizures associated with waking up in the morning. He also has 
a history of several episodes of status epilepticus (SE), leading to 
hospitalization. Seizures were initially defined to be of temporal 
origin due to early EEG-findings. However, in the context of 
comprehensive epilepsy surgery evaluation, conducted in 2005, 
the etiology of epilepsy was found to be bilateral occipital cortical 
dysplasia. Consequently, epileptogenic zone was determined to 
be located in the occipital lobe and temporal lobe was defined as 
the ictal onset zone. The patient trialed numerous AEDs, singly 
and in combination, which failed to adequately suppress his sei-
zures. VNS from 2005 to 2010 was similarly unhelpful. Due to the 
location of the known cortical dysplasia, the patient was deemed 
not a candidate for resective surgery. These circumstances led 
to consideration of installing DBS-device for our patient, and 
in November 2010, DBS electrodes (model 3389, Medtronic, 
Minneapolis, MN, USA) and an internal pulse generator (Activa 
PC, Medtronic, Minneapolis, MN, USA) were successfully 
implanted.
FIGURe 2 | (a) The onset of a deep brain stimulation (DBS) ON period (blue arrow) and the onset of an epileptic seizure (red arrow) shown in an EEG graph.  
(B) EEG graph illustrating how the ictal activity continues even after the end of DBS ON period (blue arrow). The sharp “drop” seen in the graph in some channels is 
an artifact caused by the monopolar cathodal stimulation.
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The patient’s mean seizure frequency during the five-month 
baseline period was 12.2 seizures per month, 60 of the 61 seizures 
being tonic–clonic. Early treatment with ANT-DBS resulted in 
minor—but temporary—decrease in the seizure frequency, 
possibly due to microlesion effect described in certain studies 
(3, 10). Original stimulation parameters immediately after the 
surgery were set to 5  V amplitude, 90  µs pulse width, 140  Hz 
frequency, and 1 min ON 5 min OFF cycle. Contacts labeled 2 
and 10 were initially active (Figure  1). Voltage was gradually 
increased to 7 V. As the effect of microlesion began to recede and 
the patient’s seizures returned to baseline values, active contacts 
were switched to contacts 1 and 9 (Figure 1). Again, voltage was 
first set to 5 V and then increased to 7 V. Other parameters were 
maintained at their original values. Occurrence of a SE episode 
shortly after this adjustment indicated that these stimulation 
parameters were not optimal, and the stimulator was shut down 
temporarily.
In April 2011, the patient was called in for a 3-day vEEG-
monitoring to determine the optimal stimulation parameters 
in a controlled setting. At the time, his daily medication was 
set to 1,200 mg of carbamazepine and 30 mg of clobazam. DBS 
device was switched on during the second day, and stimulation 
parameters were set to 5 V, 90 µs, 180 Hz, and 1 min ON 5 min 
OFF—with contacts 3 and 11 being active (Figure  1). Shortly 
after, at the onset of stimulator ON phase, the patient reported 
a transient visual symptom consisting of “fogginess” of vision, 
simultaneously with the onset of ANT stimulation without any 
abnormalities in the EEG pattern. Later the same day, the onset 
of stimulator ON phase simultaneously provoked seizure activity 
clearly seen in the EEG (Figure 2). Clinical manifestations of this 
seizure differed from the patient’s habitual seizures: The patient 
was seemingly able to continue his conversation with his room-
mate, but when the nurse interviewed the patient, he complained 
that colors seemed different and that the text on a magazine was 
FIGURe 3 | Seizure frequencies and the amount of seizure free days before and after the deep brain stimulation (DBS) surgery in a follow-up of 40 months. First five 
months represent the baseline seizure frequency (gray area), DBS-surgery was conducted on month 5. The vEEG-recording was conducted on month 11. Seizures 
that occurred during the video electroencephalography not included. Seizure classification according to ILAE 2017 guidelines. *Focal to bilateral tonic–clonic.
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distorted. After the settling of the seizure, the patient claimed to 
have no memory of his discussion with the nurse. During the 
third day, the patient reported several visual symptoms including 
multiple black to transparent shapes appearing and traveling in 
his field of vision.
All symptoms vanished as the stimulation voltage was decreased 
to 3 V during the third day of the recording. The voltage was later 
that day returned to the value of 5 V and in long-term stimulation 
was increased up to 7 V, uneventfully. In fact, our patient had long 
seizure free periods and his overall seizure frequency decreased 
significantly: During the last 5 months of a 40-month follow-up, 
our patient had a mean of 1.6 seizures per month. In addition, 
most of our patient’s seizures during later ANT-DBS therapy 
were his habitual focal unaware seizures instead of tonic–clonic 
seizures, which indicates that DBS prevented seizure propagation 
and reduced seizure severity (Figure 3).
DIsCUssIoN
Atypical seizures can be provoked by DBS, for example in the 
“outlier” patient of the SANTE study. Onset of these seizures 
was simultaneous with the onset of DBS, and they differed from 
the patient’s habitual seizures in seizure duration and postictal 
period—both being significantly shorter (18). The seizure type, 
complex partial seizure [focal unaware, ILAE 2017 (17)] remained 
essentially the same. At the time of onset of DBS therapy and the 
occurrence of atypical seizures, the stimulation parameters were 
set to 5 V, 90 µs, and 145 Hz. During a time period of 48 h the 
outlier patient experienced 210 of these brief seizures, after which 
the stimulation amplitude was reduced to 4  V resulting in the 
cessation of these seizures. After seven months, the stimulation 
parameters were restored to their original values and after month 
13, voltage was increased up to 9 V. However, no recurrence of the 
atypical seizure type could be witnessed.
The selection of stimulation parameters for each patient is a 
critical point in the commencement of DBS therapy. Generally, in 
DBS therapy, adjustments of the parameters produce a U-shaped 
response (19). This concept is explained by the observed change in 
symptom severity for better or worse as voltage, frequency or pulse 
width is increased from a subtherapeutic value. Gradual increase 
typically results in desired symptom alleviation. Increasing the 
parameters beyond this optimal point may, however, exacerbate 
the original symptoms or cause adverse effects. The location of 
electrodes in relation to the ANT is another important factor. 
Subtle variations in the location of the nucleus and differences 
in electrode locations even within the ANT can greatly affect 
treatment outcome (20). This also highlights the significance 
of proper  selection of active contacts, even when the electrode 
placement is accurate. Clinical benefit is rarely achieved with con-
tacts outside of or in the posterior region of ANT, likely due to the 
insulating effect of the white matter lamina surrounding the ANT 
and the more extensive connections of anterior region of the ANT 
(20). Findings in our patient are consistent with this knowledge, 
as can be seen in Figure 1. Only the topmost contacts—labeled 
3 and 11—activate a sufficient number of neurons in the anterior 
ANT to achieve seizure suppression (Figure 1E).
This case highlights the potential for a different response to 
stimulation in the initial period, compared to subsequently. In 
our case, this shift in response appears to have occurred over a 
time frame of hours, in contrast to the SANTE outlier whose ini-
tial response remained the same for a couple of days. The SANTE 
study group restored the stimulation voltage to the original value 
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only after seven months, whereas in the current case this was 
done the same day. The outlier patient received stimulation at 
4 V long enough for plasticity of the brain to possibly play a major 
role in the altered treatment response. Our patient’s brain could 
not have undergone such anatomical changes in the short time 
window he received stimulation at lower voltage—meaning there 
has to be some other mechanism.
Suggested mechanisms of DBS include short, medium and 
long-term effects (21, 22). Due to the limited time frame during 
which our patient’s response to DBS changed, we assume that 
long term effects—such as synapse plasticity—have little to no 
significance in this case. Medium-term effects include alterations 
in the levels of neurotransmitter, but their role in the current case 
cannot be adequately assessed from the patient data available. 
Another proposed mechanism is the rapid disruption of patho-
logic oscillations with DBS pulses (19, 21, 22). The systems oscil-
lator theory addresses physiologic and pathologic oscillations in 
brain networks (19). The basis of this theory is the existence of 
numerous groups of neurons, termed nodes, that act as oscilla-
tors across different networks. The nodes and oscillatory systems 
have their own frequencies, and their combined activity enables 
complex brain functions. Neurologic disorders are the result of 
flaws in this system and corruption of the information carried by 
neural networks. DBS at right parameters—frequency being the 
key one in this case—may achieve clinical benefits by resonating 
with these oscillations and correcting or amplifying the generated 
information or by simply overrunning the pathologic oscillations.
In this report, we have raised the question of how DBS can 
provoke seizures with parameters later leading to favorable treat-
ment outcome. We have also reflected on the possible mecha-
nisms responsible for these events, as well as on the possibility of 
considering findings similar to the ones described here and on the 
SANTE materials as clinical biomarkers in ANT-DBS therapy. At 
the very least, initial effects caused by stimulation should not be 
regarded outright negative, as they might be a part of the process 
in which DBS modifies brain networks.
CoNCLUDING ReMaRKs
Deep brain stimulation has successfully been used to treat mul-
tiple neurologic disorders, including epilepsy. Of the many chal-
lenges DBS faces as a treatment method for intractable epilepsy, 
the inability to reliably predict the treatment outcome is a major 
one. The discovery of an unambiguous biomarker for favorable 
clinical response to ANT-DBS would greatly aid patient selection 
for operation. This would also reduce the amount both surgery 
and stimulation-related adverse effects. Future research should 
emphasize this objective, whether by the means of electrophysi-
ological methods or different imaging techniques. This case report 
offers an insight into a possible solution to this problem using 
electroencephalography findings as possible biomarkers. Our 
hypothesis is that favorable treatment outcome can be achieved 
despite initial stimulation induced side effects.
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